LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance

U.S. Markets close in 3 hrs 7 mins

Eli Lilly and Company (LLY)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
84.35+0.17 (+0.20%)
As of 12:53PM EDT. Market open.
People also watch
BMYMRKABTGSKJNJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close84.18
Open83.90
Bid0.00 x
Ask0.00 x
Day's Range83.90 - 84.43
52 Week Range64.18 - 86.14
Volume1,122,947
Avg. Volume4,028,773
Market Cap88.79B
Beta0.20
PE Ratio (TTM)32.69
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (2.47%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin
    Business Wire2 days ago

    Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin

    Attorney Advertising. On March 17, 2017, the nationally recognized class-action law firm of Keller Rohrback L.L.P. filed suit against the nation’s three largest pharmacy benefit managers , Express Scripts , OptumRx , and CVS Caremark , and the three major insulin manufacturers, Sanofi-Aventis , Novo Nordisk , and Eli Lilly , who produce the well-known and widely-prescribed analog insulins: Lantus, ...

  • TheStreet.com3 days ago

    Eli Lilly to Invest $850M in U.S. Capital Projects This Year

    Last year, the Indianapolis-based pharmaceutical company's U.S. capital investments were $750M, according to spokesman Greg Kueterman.

  • Market Realist3 days ago

    Novartis’s Valuation Compared to Its Peers’

    Novartis’s valuation has followed the industry’s overall trend over the last five years. Whether the healthcare sector’s valuation rises or falls, Novartis will definitely be affected.